Literature DB >> 19546011

Visual perspective and genetics: a commentary on Lemogne and colleagues.

Angelina R Sutin1.   

Abstract

Lemogne and colleagues offer an interesting extension to their previous work on visual perspective and depression: Individuals at-risk for depression (defined as higher scores on Harm Avoidance), without a history of mood disorders, report retrieval of positive memories from the 3rd person perspective. Their findings suggest that the retrieval of positive experiences from the 3rd person perspective may be a risk-factor for depression, not just a lingering consequence of it. Their study, however, also reports a genetic association in a severely underpowered sample. Rather than focusing on gene x environment interactions, which large, well-powered studies on related phenotypes have failed to detect, a greater understanding of the phenomenology of visual perspective may be a more fruitful avenue for future research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546011      PMCID: PMC2763310          DOI: 10.1016/j.concog.2009.05.002

Source DB:  PubMed          Journal:  Conscious Cogn        ISSN: 1053-8100


  21 in total

1.  Episodic autobiographical memory in depression: Specificity, autonoetic consciousness, and self-perspective.

Authors:  Cédric Lemogne; Pascale Piolino; Stéphanie Friszer; Astrid Claret; Nathalie Girault; Roland Jouvent; Jean-François Allilaire; Philippe Fossati
Journal:  Conscious Cogn       Date:  2005-09-09

2.  Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.

Authors:  K P Lesch; D Bengel; A Heils; S Z Sabol; B D Greenberg; S Petri; J Benjamin; C R Müller; D H Hamer; D L Murphy
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

3.  The cognitive-affective crossfire: when self-consistency confronts self-enhancement.

Authors:  W B Swann; J J Griffin; S C Predmore; B Gaines
Journal:  J Pers Soc Psychol       Date:  1987-05

4.  Here's looking at me: the effect of memory perspective on assessments of personal change.

Authors:  Lisa K Libby; Richard P Eibach; Thomas Gilovich
Journal:  J Pers Soc Psychol       Date:  2005-01

5.  The serotonin transporter length polymorphism, neuroticism, and depression: a comprehensive assessment of association.

Authors:  Saffron A G Willis-Owen; Maria G Turri; Marcus R Munafò; Paul G Surtees; Nick W J Wainwright; Richard D Brixey; Jonathan Flint
Journal:  Biol Psychiatry       Date:  2005-07-14       Impact factor: 13.382

6.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

7.  Anxiety and depressive disorders and the five-factor model of personality: a higher- and lower-order personality trait investigation in a community sample.

Authors:  O Joseph Bienvenu; Jack F Samuels; Paul T Costa; Irving M Reti; William W Eaton; Gerald Nestadt
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505

Review 8.  Gene-environment interactions and the etiology of common complex disease.

Authors:  Richard S Cooper
Journal:  Ann Intern Med       Date:  2003-09-02       Impact factor: 25.391

9.  Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts.

Authors:  P Muglia; F Tozzi; N W Galwey; C Francks; R Upmanyu; X Q Kong; A Antoniades; E Domenici; J Perry; S Rothen; C L Vandeleur; V Mooser; G Waeber; P Vollenweider; M Preisig; S Lucae; B Müller-Myhsok; F Holsboer; L T Middleton; A D Roses
Journal:  Mol Psychiatry       Date:  2008-12-23       Impact factor: 15.992

10.  Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major depressive disorder.

Authors:  Paul G Surtees; Nicholas W J Wainwright; Saffron A G Willis-Owen; Robert Luben; Nicholas E Day; Jonathan Flint
Journal:  Biol Psychiatry       Date:  2005-09-09       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.